21 Oct Innovations in Vitreous Macula Retina
Innovations in Vitreous Macula Retina
Presented by: J. Sebag MD, FACS, FRCOphth, FARVO
Tuesday, October 27th, 2015
4:00 – 5:00 PM
Research Conference Center
734 Fairmount Avenue Pasadena, CA 91105
J. Sebag, MD of VMR Institute for Vitreous Macula Retina
About the talk:
Click to view the flier
This lecture will review the biochemistry, anatomy, and physiology of the vitreous body, with emphasis on the vireo-retinal interface. Proteomic studies of in utero human vitreous development will be presented that may provide insights into the underlying mechanisms of blood vessel regression, perhaps opening new avenues of R&D to control pathologic ocular neovascularization and systemic metazoic carcinoma. The pathophysiologic mechanisms resulting in various disease such as rhegmatogenous retinal detachment and macular holes will be reviewed, standard of care therapies will be described and demonstrated with video recordings, and new forms of non-surgical pharmacologic vitreolysis therapy will be presented.
Learning objectives:
- Understand how developmental and aging changes in vitreous impact the macula and retina to cause vision loss.
- Recognize when vitro-retinal pathologies are potential causes of vision loss and refer patients accordingly.
- Appreciate the surgical therapies available today and refer patients to surgeons able to treat these conditions.
- Understand the ways that pharmacotherapies are beginning to replace surgical interventions.
Audience appeal:
Researchers, clinicians and students of medicine and science.